KNOWLEDGE BANK

Interviews

GE Healthcare

President & CEO
Our current business focus and strengths are in the areas of bioprocessing proteins cellular analysis cell handling and tools for cell therapy Our strategic intent is to add adjacent technologies or applications which can add value to the overall customer solutions we provide We are particularly excited about the sample collection and storage opportunity with the FTA product lineWe have a stron...

Articles

Transforming Customer Engagement in Life Sciences Adopting Hybrid Commercial Models (HCMs)

The convergence of traditional and digital channels in the life sciences industry presents significant challenges in delivering a comprehensive Customer Experience CX across all touchpoints Before Healthcare Professionals HCPs primarily engaged with life science enterprises through traditional means such as facetoface meetings

Research Insights

Clinically Adjudicated Deceased Donor Acute Kidney Injury and Graft Outcomes

Acute kidney injury AKI in deceased donors is not associated with graft failure GF We hypothesize that hemodynamic AKI hAKI comprises the majority of donor AKI and may explain this lack of association Less than of patients on the waiting list receive kidney transplants each year and approximately thirteen

Case Studies

Effects Of Particle Size On The Triboelectrification Phenomenon In Pharmaceutical Excipients: An Experimental Case Study

Abstract Particle sizes play a major role to mediate charge transfer both between identical and different material surfaces The study probes in to the probable mechanism that actuates opposite polarities between two different size fractions of the same material by analyzing the charge transfer patterns of two different sizes of MCC Quantum scale calculations

Techno Trends

Insmed Announces ARIKAYCE® For the Treatment of Mycobacterium Avium Complex (MAC) Lung Disease

Insmed Inc announced ARIKAYCE amikacin liposome inhalation suspension for the treatment of Mycobacterium Avium Complex MAC lung disease as part of a combination antibacterial drug regimen for adult patients ARIKAYCE can be used for patients with MAC lung disease a chronic and debilitating condition that can significantly increase patient morbidity and mortality...

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Nanotechnology Strategies for Age –Related Macular Degeneration

Aira Sarkar

Aira Sarkar is pursuing B. Tech (Pharmaceutical Chemistry and Technology) in Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT).

 

Sathish Dyawanapelly

Sathish Dyawanapelly is working as an Assistant Professor in Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT).

 

2

The Exosome Manufacturing Gap

Dr Deepika Arora

Dr Deepika Arora is an accomplished professional with expertise in project management, process improvement, and operational excellence. She brings strong scientific expertise and experience in prolific biologics, contributing to innovation and quality-driven outcomes. With a commitment to continuous learning, she has led cross-functional initiatives across diverse industries and writes on leadership, strategy, and professional development.

Aditya Banerjee

Aditya Banerjee is a senior scientist specialising in stem cell biology, regenerative medicine, and translational research. His work focuses on GMP-compliant cell therapy manufacturing, exosome research, and quality systems. Passionate about advancing scientific innovation, he writes on emerging biotechnologies, laboratory excellence, and their translation into meaningful clinical applications.

3

Architecting the Modern MICC for Life Sciences GCCs

Tansshuman Das

Tanshuman Das is a life sciences technology and commercial leader with 17+ years of experience across pharmacovigilance, AI, CRO services and drug safety technology. He leads Sales & Marketing at Synapmed and focuses on translating AI and intelligent automation into practical, scalable solutions for life sciences organisations.

4

The Value in Decolonising Drug Discovery

Jesse Grey Eagle

Jesse Grey Eagle (Oglala Lakota) is the founder of Indigenous Futures OS and a governance designer for Tribal nations. He works at the nexus of ethical data, AI sovereignty, and long-view institutional systems, advocating for partnership architectures that move beyond extraction.

Dr. Sabah Ul-Hasan

Sabah Ul-Hasan is a Ph.D. scientist with over 15 years of practice in the life sciences. An Indian-Pakistani American based in Albuquerque (New Mexico), Dr. Ul-Hasan centers on ethical data practices that bridge science with community-based knowledge systems.

5

Boosting NICU Safety

Norhan Attia

Norhan Attia, clinical pharmacist with five years' experience at Assiut University Hospital, Egypt, specialising in Neonatal Intensive Care. Expert in medication reviews, IV admixtures, and optimising pharmacotherapy outcomes. Currently a dedicated teaching assistant, focusing on pharmaceutical education and enhancing medication safety in NICU settings.

press releasesRead more...

Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery

AIdriven protein design is accelerating the discovery of novel protein binders but experimental validation remains essential to determine whether computational designs translate into meaningful target interactions To bridge this gap Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in r...

Innovent Announces Positive CHMP Opinion, Recommending Zybrivo® (sintilimab) for First-Line Treatment of Non-squamous Non-Small Cell Lung Cancer

Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncologic autoimmune cardiovascular and metabolic

Biocon Limited BSE NSE BIOCON an innovationled global biopharmaceutical company today announced that the US Food and Drug Administration FDA has approved Pebrilzo pertuzumabqcay a biosimilar of the reference

LOTTE Biologics Secures Major Commercial Manufacturing Agreement Ahead of Songdo Plant 1 Launch

LOTTE Biologics CoCEOs James Park and Yooyeol Shin today announced a major commercial manufacturing agreement with a global pharmaceutical company marking a significant milestone in the commercialization of its Songdo Bio Campus

Akeso Announces NMPA Acceptance of sNDA for Ivonescimab in Combination with Chemotherapy for First-Line Biliary Tract Cancer

Akeso Inc HK Akeso or the Company announced that the National Medical Products Administration NMPA of China has accepted the supplemental New Drug Application sNDA for ivonescimab in combination with chemotherapy

Biomapas Establishes Us Presence With Acquisition of Alira Health’s Cmc Business

Biomapas a leading integrated life sciences services provider today announced its entry into the US market with the acquisition of the Chemistry Manufacturing and Controls CMC business of Alira Health The Bostonbased team which provides integrated

EventsRead more...

24 - 27

Nov 2026

Pharmtech & Ingredients 2026

Crocus Expo, Pavilion 2, Mosco...

24 - 25

Nov 2026

BioPharma Deals Conference 2026

Science Congress Center, Munic...

26 - 28

Nov 2026

One Health Conference 2026

Thapar Institute of Engineerin...

01 - 03

Dec 2026

Pharmaceutical Launch Excellence Summit

Novotel Amsterdam City, Nether...

01 - 03

Dec 2026

10th Antifibrotic Drug Development

Boston, MA at the Hotel Common...

02 - 04

Dec 2026

Genome Informatics 2026

Wellcome Genome Campus, UK

03 - 04

Dec 2026

LATEST NEWSRead more...

OBI Pharma and Novartis Partner to Develop Next-Generation ADCs for Cancer Treatment

OBI Pharma has entered into a collaboration and licensing agreement with Novartis to develop nextgeneration antibodydrug conjugates ADCs using novel payloads and OBIs proprietary technology platforms

Merck to Acquire Rapid Micro Biosystems to Strengthen Automation in Pharmaceutical Quality Control

Merck has signed a definitive agreement to acquire Rapid Micro Biosystems a USbased provider of automated microbial qualitycontrol testing solutions for pharmaceutical manufacturing

Immuneering Enters into Collaboration with Astellas to Evaluate Combination Therapies for Pancreatic Cancer

Immuneering has entered into a clinical trial collaboration and supply agreement with Astellas Pharma to evaluate investigational combination therapies for patients with pancreatic cancer

Eppendorf Invests €40 Million in New Manufacturing Facility in Penang, Malaysia

Eppendorf has started construction of a new manufacturing facility at Bandar Cassia Technology Park in Penang Malaysia

Lilly Invests US$3.5 Billion in New Manufacturing Facility for Obesity Medicines in Pennsylvania

Eli Lilly and Company has started construction of a US billion manufacturing facility in Lehigh Valley Pennsylvania as part of its plans to expand medicine production in the United States The new site is one of manufacturing facilities

Natera Enters into Collaboration with Incyte for Phase II Trial in Colorectal Cancer

Natera a precision medicine company has entered into a clinical collaboration with Incyte to support a new Phase II study evaluating an investigational treatment for colorectal cancer CRC